David H Vesole

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Multiple Myeloma

Mild Cognitive Impairment

Top Venues

Leukemia & lymphoma

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Tina Roy, Joseph B An, Kimberly Doucette, Aimee M Chappell, David H Vesole
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression. Leukemia & lymphoma 63 (3) (2022)
Noa Biran, Elli Gourna Paleoudis, Rena Feinman, David H Vesole, Joshua Zenreich, Shuqi Wang, Jaeil Ahn, Meena B Bansal, Scott Douglas Rowley, Michele L Donato, Andrew L Pecora, Joshua Richter, Palka Anand, Laura McBride, Kristin Ivanovski, Robert Korngold, David S Siegel
Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma. American journal of hematology 96 (11) (2021)
Noa Biran, Wanting Zhai, Roxanne E Jensen, Jeanne S Mandelblatt, Susan Kumka, Rashmi Unawane, Kristi D Graves, David H Vesole, David S Siegel, Arnold L Potosky
Patient-reported outcomes following autologous stem cell transplant for patients with multiple myeloma. EJHaem 2 (3) (2021)